Journal
FOODS
Volume 11, Issue 21, Pages -Publisher
MDPI
DOI: 10.3390/foods11213488
Keywords
defatted rice bran; colitis-associated colorectal cancer; chemoprevention; anti-inflammation; anti-cell proliferation; health; health product
Categories
Funding
- Thailand Research Fund (TRF)
- Researchers for Industries (RRI) Scheme [PHD62I0006]
- Thai Ruam Jai Vegetable Oil Co., Ltd. (Phra Nakhon Si Ayutthaya, Thailand)
- Agricultural Research Development Agency (Public Organization) or ARDA [PRP6405030310]
Ask authors/readers for more resources
Defatted rice bran (DRB) is a popular food with nutritional and functional aspects. This study found that DRB supplementation has a chemopreventive effect on colitis-associated colorectal cancer (CRC) in rats, reducing CRC symptoms and inhibiting inflammation and cancer cell proliferation. These findings suggest that DRB could be a natural dietary chemopreventive agent for cancer prevention.
Defatted rice bran (DRB) is gaining immense popularity worldwide because of its nutritional and functional aspects. Emerging evidence suggests that DRB is a potential source of dietary fiber and phenolic compounds with numerous purported health benefits. However, less is known about its chemoprotective efficacy. In the present study, we determined and examined the nutrient composition of DRB and its chemopreventive effect on azoxymethane and dextran sulphate sodium (AOM/DSS)-induced colitis-associated colorectal cancer (CRC) in rats. The results showed the presence of several bioactive compounds, such as dietary fiber, phytic acid, and phenolic acids, in DRB. In addition, DRB supplementation reduced the progression of CRC symptoms, such as colonic shortening, disease activity index (DAI), and histopathological changes. Interestingly, a significant decrease was observed in total numbers of aberrant crypt foci (ACFs) and tumors with DRB supplementation. Furthermore, DRB supplementation suppressed the expression of pro-inflammatory cytokines (IL-6) and inflammatory mediators (NF-kappa B and COX-2) through the inactivation of the NF-kappa B signaling pathway. The administration of DRB revealed a negative effect on cancer cell proliferation by repressing the expression of nuclear beta-catenin, cyclin D1, and c-Myc. These findings suggest that DRB supplementation mitigates chronic inflammation and cancer cell proliferation and delays tumorigenesis in rat AOM/DSS-induced colitis-associated CRC. Therefore, the establishment of DRB as a natural dietary food-derived chemopreventive agent has the potential to have a significant impact on cancer prevention in the global population.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available